Southern Symposium on Foregut Cancers


Cork 2012

Symposium Webcasts

Welcome Address and Opening

Speaker Affiliation Presentation
Dr Susan O Reilly Director, National Cancer Control Programme Progress in Cancer Care: Colorectal Perspective play

Controversies in Colorectal Cancer

Speaker Affiliation Presentation
Mr Garrett Nash Consultant Colorectal Surgeon, Memorial Sloan Kettering Cancer Center, New York Peritoneal Carcinomatosis: What is the Optimal Treatment? The Surgery Perspective play
Professor Phil Quirke Professor of Pathology, School of Medicine, University of Leeds, UK What is Bad Prognosis Stage II Colon Cancer? What Your Pathologist Can Tell You play
Prof David Sebag Montefiore Professor of Clinical Oncology, University of Leeds, UK FOR: A DEBATE : ‘T3 Rectal Cancer in the Era of TME: What is the Optimal Treatment?’ play
Mr Myles Joyce Consultant Surgeon, Galway University Hospital, Galway AGAINST: A DEBATE : ‘T3 Rectal Cancer in the Era of TME: What is the Optimal Treatment?’ play
Dr. Brian O'Neill Consultant Radiation Oncologist, St Luke’s & Beaumont Hospitals, Dublin. Short Course Radiotherapy VS Long Course Chemoradiotherapy for Rectal Cancer play

Updates in the Surgical Management of Colorectal Cancer

Speaker Affiliation Presentation
Mr Mícheál Ó Ríordáin Consultant Colorectal Surgeon, Mercy University Hospital, Cork. Laparoscopic Surgery for Colorectal Cancer play
Mr David Jayne Senior Lecturer, University of Leeds/Consultant Surgeon, Leeds Teaching Hospitals NHS Trust, UK. Robotic Surgery for Colorectal Cancer play
Dr Derek Power Consultant Medical Oncologist, Mercy University Hospital, Cork. Inherited Colorectal Cancer Syndromes - Who Should be Tested? play
Dr John L Marshall Chief, Hematology and Oncology / Professor of Medicine and Oncology / Associate Director of Clinical Research / Director, Otto J Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington. KEY NOTE SPEAKER
Managing Colon Cancer in the Era of Personalised Medicine

Day 2: Welcome Address

Speaker Affiliation Presentation
Professor Graeme Poston Consultant Hepato-biliary Surgeon, University Hospital Aintree, Liverpool, & Professor of Surgery of the University of Liverpool, UK. An Overview: Improved Survival in Metastatic Colorectal Cancer is Associated with Adoption of Hepatic Resection and Chemotherapy play


Speaker Affiliation Presentation
Professor Dushyant V Sahani Director of CT, Associate Professor of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, USA The Role of Cross Sectional Imaging and Ultrasound in Liver Resection and Follow Up play
Dr Kevin O’Regan Consultant Radiologist, Cork University Hospital, Cork Is Metabolic Imaging Prior to Liver Resection Necessary? play


Speaker Affiliation Presentation
Professor David C Linehan Chief, Division of General Surgery, Section of Hepatobiliary-Pancreatic and Gastrointestinal Surgery, Washington University Cancer Centre, St. Louis, USA Definitions of Resectability and the Evolution of Surgical Strategies play
Professor Maria B. Majella Doyle Assistant Professor of Surgery and Director of the HPB Fellowship Program, Division of General Surgery, Section of Abdominal Transplantation, Washington University in St Louis Synchronous or Metachronous Resection of Liver Metastases and Primary Colorectal Cancer play
Professor Michael I D’Angelica Department of Surgery, Hepatopancreaticobiliary Service, Memorial Sloan Kettering Cancer Centre, New York, USA Resection of Extrahepatic Disease: Why and When? play

Systemic Chemobiologic Therapy

Speaker Affiliation Presentation
Dr Geoff Ku Attending Medical Oncologist, Dept of Gastrointestinal Oncology Memorial Sloan Kettering Cancer Centre, New York, USA Anti-EGFR Therapies: The more we know... play
Dr Neil Segal Attending Medical Oncologist, Dept of Gastrointestinal Oncology, Memoial Sloan Kettering Cancer Centre, 4 New York, USA Evolution of Systemic Therapy with a Focus on Anti-Angiogenic Strategies and Beyond play
Professor Aimery De Gramont Head of the Medical Oncology Service, Hopital Saint-Antoine, Paris, France New Paradigms for the Treatment of Metastatic Colorectal Cancer (MCRC) play

Regional Therapy

Speaker Affiliation Presentation
Professor Nancy E Kemeny Attending Medical Oncologist, Department of Medicine, Gastrointestinal Oncology, Service, Memorial Sloan Kettering Cancer Centre, New York, USA Hepatic Arterial Infusion in Liver Resection – State of the Art play
Dr Richard A Sharma Consultant Clinical Oncologist, Department of Radiation Oncology, University of Oxford, Churchill Hospital, Oxford, UK Yttrium-Labeled Microspheres play
Mr Emir Hoti Consultant Hepatopancreaticobiliary Surgeon, Department of Surgery, St Vincent’s University Hospital, Dublin Ablative Therapies play

Back to Top